Neurovalens Celebrates 2024 SleepTech Award Recognition

Neurovalens Wins Prestigious 2024 SleepTech Award

Neurovalens, a leader in health technology focusing on neurotechnology, has received the esteemed 2024 SleepTech Award from the National Sleep Foundation (NSF) for its groundbreaking product, Modius Sleep. This accolade recognizes the effectiveness of Modius Sleep, a noninvasive, FDA-cleared device designed specifically to tackle chronic insomnia.

Join Us at CES 2025

As a result of this significant achievement, Neurovalens will attend CES 2025, where they will collaborate with NSF to explore innovations in sleep technology. The event, taking place in Las Vegas, is poised to be a pivotal moment to address developments that enhance brain health through improved sleep.

Highlighting the Impact of Modius Sleep

Modius Sleep leverages advanced neurostimulation technology aimed at enhancing sleep patterns. This device targets the brain regions that are crucial for sleep regulation, providing users with a drug-free alternative to traditional insomnia treatments. The NSF recognizes this innovative approach as essential to future sleep health solutions.

Panel Discussion on Sleep and Brain Health

At CES 2025, Kate Willis, Vice President of Commercialization at Neurovalens, will participate in a panel discussion titled "SleepTech: A Gateway to Brain Health." This session will delve into the relationship between sleep and cognitive wellness, spotlighting technologies like Modius Sleep and their potential to transform overall health.

Voices from Neurovalens Leadership

Dr. Jason McKeown, CEO of Neurovalens, expressed enthusiasm over their participation at CES 2025. He stated, "We are honored to join the National Sleep Foundation and humbled to receive the 2024 SleepTech Award. This recognition strengthens our dedication to advancing sleep health through innovative technology. Modius Sleep is enhancing lives and redefining the future of sleep and brain health."

Visitor Engagement at CES

CES attendees are invited to visit the NSF booth at the Venetian (Booth 53607) to experience Modius Sleep firsthand. The opportunity to engage with this innovative device showcases Neurovalens' commitment to health improvement through advanced technology solutions.

About Modius Sleep

Modius Sleep is renowned for its pioneering approach to addressing chronic insomnia. It offers a safe and effective method of promoting better sleep without medication. By using low-level electrical stimulation, this device helps users to achieve a more restorative sleep cycle, which is crucial for overall well-being.

About Neurovalens

Neurovalens is a forward-thinking health-tech company dedicated to creating non-invasive neurostimulation devices that address significant health challenges. Headquartered in Belfast, the company aims to revolutionize health by using electrical signals to enhance functions like sleep, stress management, and general health. For those interested in learning more, details about Neurovalens and its products can be found on their official website.

About the National Sleep Foundation

The National Sleep Foundation is a nonprofit organization focused on enhancing health and well-being through better sleep education and advocacy. They are committed to advancing research and practice in sleep health since their establishment in 1990.

Frequently Asked Questions

What is the 2024 SleepTech Award?

The 2024 SleepTech Award recognizes innovative products that enhance sleep health, awarded by the National Sleep Foundation.

What is Modius Sleep?

Modius Sleep is a noninvasive, FDA-cleared device designed to help individuals combat chronic insomnia through neurostimulation technology.

Where can I see Neurovalens at CES 2025?

Neurovalens will be present at the NSF booth located in the Venetian (Booth 53607) during CES 2025.

Who is speaking at the CES 2025 panel on sleep?

Kate Willis from Neurovalens will join industry leaders, including NSF CEO John Lopos, to discuss sleep technology and its impact on brain health.

What is the goal of Neurovalens?

Neurovalens aims to create non-invasive health solutions that address significant issues like sleep disorders and overall health, using innovative neurotechnology.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.